555 results on '"Galldiks, N."'
Search Results
2. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
3. Introducing the American Society of Neuroradiology PET-Guided Diagnosis and Management in Neuro-Oncology Study Group
4. Hirnmetastasen – interdisziplinär zu einer personalisierten Behandlung
5. Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology:The EANO positive action initiative
6. Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI
7. CHAPTER 16. Brain
8. P01.01.A Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients
9. P01.02.B Case Report: Disruption of Resting-State Networks and Cognitive Deficits After Whole Brain Irradiation for Singular Brain Metastasis
10. P11.53.B Efficacy and tolerability of regorafenib in pretreated patients with progressive CNS grade 3 or 4 gliomas
11. PL01.6.A Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases
12. P15.05.A Prediction of response to lomustine-based chemotherapy in glioma patients at relapse using MRI and FET PET
13. KS05.5.A Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
14. P17.19.B Incidence of treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma treated with cilengitide (EORTC 26071 - CENTRIC study): interim analysis
15. P13.03.A Radiomics for the non-invasive assessment of the PDL-1 expression in patients with non-small cell lung cancer brain metastases
16. KS02.7.A Impact of FET PET on multidisciplinary neurooncological tumor board decisions in patients with brain tumors
17. Immuntherapie und zielgerichtete Therapie von Gliomen
18. Impact of 18F-FET PET imaging to differentiate tumour progression vs therapy induced changes following immunotherapy with DC vaccination in glioblastoma patients
19. Radiomics for the non-invasive assessment of the PDL-1 expression in patients with non-small cell lung cancer brain metastases
20. Individual prediction of response to radiosurgery for brain metastases - radiomics outperforms visual semantic features
21. RADIOMICS FOR THE NON-INVASIVE ASSESSMENT OF THE PDL-1 EXPRESSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES
22. LESION-FUNCTION ANALYSIS FROM MULTIMODAL IMAGING AND NORMATIVE BRAIN ATLASES FOR PREDICTION OF COGNITIVE DEFICITS IN GLIOMA PATIENTS
23. Impact of FET PET on multidisciplinary neurooncological tumor board decisions in patients with brain tumors
24. CASE REPORT: DISRUPTION OF RESTING-STATE NETWORKS AND COGNITIVE DEFICITS AFTER WHOLE BRAIN IRRADIATION FOR SINGULAR BRAIN METASTASIS
25. PREDICTION OF RESPONSE TO LOMUSTINE-BASED CHEMOTHERAPY IN GLIOMA PATIENTS AT RELAPSE USING MRI AND FET PET
26. RADIOMICS OUTPERFORMS SEMANTIC FEATURES FOR PREDICTION OF RESPONSE TO STEREOTACTIC RADIOSURGERY IN BRAIN METASTASES
27. INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS
28. ALTERATIONS IN WHITE MATTER FIBER DENSITY ASSOCIATED WITH STRUCTURAL MRI AND METABOLIC PET LESIONS FOLLOWING MULTIMODAL THERAPY IN GLIOMA PATIENTS
29. EFFICACY AND TOLERABILITY OF REGORAFENIB IN PRETREATED PATIENTS WITH PROGRESSIVE CNS GRADE 3 OR 4 GLIOMAS
30. INCIDENCE OF TREATMENT-ASSOCIATED IMAGING CHANGES IN NEWLY DIAGNOSED MGMT PROMOTER-METHYLATED GLIOBLASTOMA TREATED WITH CILENGITIDE (EORTC 26071-CENTRIC STUDY): INTERIM ANALYSIS
31. Multimodal PET/MRI radiomics and clinical parameters for overall survival prediction in patients with IDH wildtype glioblastoma
32. Use of Neuroimaging Techniques in Glioma Patients – Results of an International Survey on behalf of the EORTC Brain Tumor Group
33. Lesion-Function Analysis from Multimodal Imaging and Normative Brain Atlases for Prediction of Cognitive Deficits in Glioma Patients
34. Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation
35. 18F-FET PET imaging following immunotherapy with DC vaccination in glioblastoma patients
36. P14.06 Radiomics for the non-invasive determination of the BRAF mutational status in patients with melanoma brain metastases
37. P14.41 Cost-effectiveness of FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy
38. P14.79 Differentiation of treatment-related changes from tumor progression following brachytherapy in patients with WHO II and III gliomas using FET PET
39. OS03.3.A Characterization of long-term metabolic changes of irradiated brain metastases using serial dynamic FET PET imaging
40. Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas: Results of a prospective phase II study
41. Selective Immune Adsorption Treatment of Severe Guillain Barré Syndrome in the Intensive Care Unit
42. Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen
43. Introducing the American Society of Neuroradiology PET-Guided Diagnosis and Management in NeuroOncology Study Group.
44. 11C-Flumazenil positron emission tomography demonstrates reduction of both global and local cerebral benzodiazepine receptor binding in a patient with Stiff Person Syndrome
45. Tumour-infiltrating effector T-cells and false-positive identification of tumour progression by MRI and 18FET-PET after dendritic cell vaccination in newly-diagnosed glioblastoma patients
46. Brain metastases-Interdisciplinary approach towards a personalized treatment
47. Non-invasive prediction of the BRAF mutation status in patients with melanoma brain metastases using MRI radiomics
48. Autologous tumour-lysate loaded dendritic cell vaccination alters the phenotype of tumour-infiltrating lymphocytes in newly diagnosed glioblastoma patients
49. 18F-FET PET imaging following immunotherapy with DC vaccination in glioblastoma patients
50. Deep brain stimulation of the subthalamic nucleus reversibly deteriorates stuttering in advanced Parkinson’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.